These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33614957)

  • 41. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic value of baseline serum luteinizing hormone level for central precocious puberty in girls].
    Ou-Yang LX; Yang F
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):729-733. PubMed ID: 28697822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty.
    Chen T; Yu W; Xie X; Ge H; Fu Y; Yang D; Zhou L; Liu X; Yan Z
    Front Neurol; 2020; 11():17. PubMed ID: 32082242
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty.
    Klein K; Yang J; Aisenberg J; Wright N; Kaplowitz P; Lahlou N; Linares J; Lundström E; Purcea D; Cassorla F
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1241-1248. PubMed ID: 26887034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgen selectively stimulates follicle-stimulating hormone-beta mRNA levels after gonadotropin-releasing hormone antagonist administration.
    Wierman ME; Wang C
    Biol Reprod; 1990 Mar; 42(3):563-71. PubMed ID: 2111188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation.
    Lee PA; Luce M; Bacher P
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1249-1257. PubMed ID: 27740929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
    Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
    J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty.
    Cook JS; Doty KL; Conn PM; Hansen JR
    J Clin Endocrinol Metab; 1992 May; 74(5):1206-9. PubMed ID: 1569169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
    Kunz GJ; Sherman TI; Klein KO
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty.
    Lewis KA; Eugster EA
    Drug Des Devel Ther; 2009 Sep; 3():1-5. PubMed ID: 19920916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating ghrelin levels in girls with central precocious puberty are reduced during treatment with LHRH analog.
    Maffeis C; Franceschi R; Moghetti P; Camilot M; Lauriola S; Tatò L
    Eur J Endocrinol; 2007 Jan; 156(1):99-103. PubMed ID: 17218731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone Density in Transgender Youth on Gender-Affirming Hormone Therapy.
    Roy MK; Bothwell S; Kelsey MM; Ma NS; Moreau KL; Nadeau KJ; Rothman MS; Nokoff NJ
    J Endocr Soc; 2024 Mar; 8(5):bvae045. PubMed ID: 38562129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Gonadotropin-Releasing Hormone (GnRH) Stimulation Test Before and After GnRH Analogue Treatment for Central Precocious Puberty: Has the GnRH Test been Adequately Simplified?
    Kim MS; Hwang PH; Lee DY
    Indian J Pediatr; 2015 Nov; 82(11):996-1000. PubMed ID: 25956950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty.
    Wojniusz S; Callens N; Sütterlin S; Andersson S; De Schepper J; Gies I; Vanbesien J; De Waele K; Van Aken S; Craen M; Vögele C; Cools M; Haraldsen IR
    Front Psychol; 2016; 7():1053. PubMed ID: 27462292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resolution of precocious puberty following resection of fourth ventricular medulloblastoma: case report.
    Medina RG; Dempsher DP; Gauvain KM; Geller TJ; Elbabaa SK
    J Neurosurg Pediatr; 2015 Sep; 16(3):287-90. PubMed ID: 26053334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basal luteinizing hormone/follicle stimulating hormone ratio in diagnosis of central precocious puberty.
    Supornsilchai V; Hiranrat P; Wacharasindhu S; Srivuthana S; Aroonparkmongkol S
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S145-51. PubMed ID: 12929982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls.
    Houk CP; Kunselman AR; Lee PA
    Pediatrics; 2009 Jun; 123(6):e1059-63. PubMed ID: 19482738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty.
    Wiromrat P; Panamonta O
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):227-233. PubMed ID: 30592192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty.
    Wu V; Zhao V; Issa R; Wilkes M; Wallach E; Rapaport R; Romero C; Yau M
    Ann Pediatr Endocrinol Metab; 2021 Sep; 26(3):185-191. PubMed ID: 34015904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presentation of 493 consecutive girls with idiopathic central precocious puberty: a single-center study.
    Giabicani E; Allali S; Durand A; Sommet J; Couto-Silva AC; Brauner R
    PLoS One; 2013; 8(7):e70931. PubMed ID: 23936254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.